Results 41 to 50 of about 9,580 (245)
Background The globally concerning outbreak of monkeypox virus (MPXV) in non-endemic countries in 2022 warranted an increased capacity of diagnostic clinical testing.
Katharine Uhteg, H. Mostafa
semanticscholar +1 more source
a CRISPR-Cas12a-based detection assay for monkeypox virus (MPXV) 1 . Nucleic acid the methods The diagnosis monkeypox MPXV Rapid detection are in detection of potentially they can provide in a cost-effective As a we monoclonal antibody-based antigens ...
Mengjun Li +13 more
semanticscholar +1 more source
Trends of Pathogenicity and Potential Risk Evaluation of Central African Mpox Variant to Cause Global Public Health Emergency: A Cross-Sectional Analysis. [PDF]
ABSTRACT Background With the re‐emergence of monkeypox (Mpox), it is vital for communities to assess and effectively respond to emerging outbreaks. This paper aims to review the potential of clade I Mpox to result in a widespread outbreak by assessing genetically enhanced virulence, transmission, and clinical manifestations.
Rahman MA +5 more
europepmc +2 more sources
In May 2019, we investigated monkeypox in a traveler from Nigeria to Singapore. The public health response included rapid identification of contacts, use of quarantine, and postexposure smallpox vaccination. No secondary cases were identified.
Sarah Ee Fang Yong +22 more
doaj +1 more source
ENDEMIC ORTHOPOXVIRUS CIRCULATING IN PROCYONIDS IN MEXICO [PDF]
Limited serosurveillance studies suggested that orthopoxviruses (OPXV) are widespread in the US (e.g., Raccoonpox virus, Skunkpox virus, Volepox virus) and Brazil (Vaccinia virus); however, their animal reservoir(s) remain unconfirmed. Mexican mammal diversity includes several species related to those in which evidence for OPXV infections has been ...
Nadia F, Gallardo-Romero +13 more
openaire +2 more sources
Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
Modified vaccinia virus Ankara (MVA) is the vector of choice for human and veterinary applications due to its strong safety profile and immunogenicity in vivo.
Malachy I. Okeke +7 more
doaj +1 more source
Since May 2022, mpox has been identified in 108 countries without endemic disease; most cases have been in gay, bisexual, or other men who have sex with men.
Faisal S. Minhaj +21 more
doaj +1 more source
Orthopoxviruses (OPXVs) not only infect their natural hosts, but some OPXVs can also cause disease in humans. Previously, we partially characterized an OPXV isolated from an 18-year-old male living in Northern Norway.
Diana Diaz-Cánova +4 more
semanticscholar +1 more source
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications
Introduction Tecovirimat (TPOXX®; ST-246) was approved for the treatment of symptomatic smallpox by the USFDA in July of 2018 and has been stockpiled by the US government for use in a smallpox outbreak.
Andrew T. Russo +8 more
semanticscholar +1 more source
The eradication of smallpox and subsequent cessation of vaccination have left a majority of the population susceptible to variola virus or other emerging poxviruses. This is exemplified by human monkeypox, as evidenced by the increase in reported endemic
E. Mucker +8 more
semanticscholar +1 more source

